Cambridge Major
Laboratories Inc. (CML), a world-class supplier of comprehensive pharmaceutical
development and manufacturing services, is investing more than $20 million in
its R&D and manufacturing facilities in Germantown. The project will
include a new administrative headquarters, as well as an expansion of the
company’s R&D and manufacturing capacity to service the global
pharmaceutical industry.

The expansion,
which is scheduled to be completed by the end of 2015, is expected to create 75
new jobs over the next three years.

“This project
demonstrates CML’s commitment to increasing its research and development
efforts in Wisconsin as the company continues to serve the pharmaceutical
industry by developing and manufacturing active pharmaceutical ingredients
(APIs) for life-saving drugs,” said Governor Scott Walker. “The center also
will provide dozens of new family-supporting jobs in Washington County as CML
adds new scientists, engineers and other professionals to its staff.”

“We are pleased to
be expanding our pharmaceutical services presence and capabilities in
Wisconsin,” said Stephan Kutzer, CEO of AAIPharma Services and
CML. “Wisconsin’s strong base of research universities and talented
workforce, combined with the support of the State of Wisconsin, Washington
County and the Village of Germantown, contributed to our decision to make
significant additional investments in our active pharmaceutical ingredient
operations in Germantown.”

“Partnering local
and state agencies to fuel CML’s expansion demonstrates our focus on
leveraging  the unique capabilities of each entity in making a decisive
difference for existing growth companies and job creators in Washington
County,” added Christian Tscheschlok, executive director of Economic
Development Washington County (EDWC). “By investing in both CML and its future
workers at this important juncture in the company’s evolution, EDWC and its
partners didn’t hesitate to maximize this opportunity for the company’s
successful growth.”

To support the
project, the Wisconsin Economic Development Corporation (WEDC) has authorized
up to $800,000 in Jobs Tax Credits for the company over the next three years.
The actual amount of tax credits awarded will depend upon the number of jobs
created during that period.

“Wisconsin, thanks
in large part its strong university system, already is a leader in research and
development in many areas, including pharmaceuticals,” said Reed Hall,
secretary and CEO of WEDC, the state’s lead economic development organization.
“CML is continuing to advance R&D in the state by making this kind of
commitment, and we’re pleased that WEDC is playing a major role in establishing
the new center.”

The Wisconsin
Department of Workforce Development (DWD) also recently issued its intent to
award CML a $400,000 Wisconsin Fast Forward worker training grant. The grant
will support the training of more than 250 existing and new employees through a
new, industry-specific training program that embeds career development with
continuous improvement and learning.

Department of Workforce Development supports innovative training solutions that
help workers develop skills that are in demand by employers,” DWD
Secretary Reggie Newson said. “These are the kinds of innovative programs
that make Wisconsin a leader in addressing the skills gap and ensuring a talent
pipeline for employers in our state.”

The Village of
Germantown and Washington County joined forces to provide a $280,000 loan
through the county’s Attraction Fund that allows for principal forgiveness
should CML meet certain jobs and new investment performance criteria. If those
criteria are met, the loan will be repaid with revenue generated by an existing
Tax Increment District. The county also provided a $200,000 low-interest loan
from its County Impact Revolving Loan Fund. In addition, the village provided
incentives not to exceed $378,000.

CML recently
joined with AAIPharma Services Corp. to form a world-class supplier of
comprehensive pharmaceutical development and manufacturing services. With more
than 800 employees operating out of seven sites in the U.S. and Europe, the
combined capabilities include API development and manufacturing, solid state
chemistry,  formulation development, analytical development and testing
services, clinical and commercial finished dosage form manufacturing (solid
dose and parenteral), packaging, and stability services.

Germantown is home
to CML’s U.S. API development and manufacturing headquarters, which employs
about 180 workers in a state-of-the-art, 60,000-square-foot facility. The site
has all of the capabilities required to provide API development and API
manufacturing services from early pre-clinical to commercial production.